SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin's US arm recalling 11,706 bottles of hypertension drug in US

23 Aug 2018 Evaluate

Lupin’s US subsidiary, Lupin Pharmaceuticals Inc is recalling 11,706 bottles of Lisinopril tablets, used for treating hypertension, from the American market. The product is in the strength of 10mg. 

The reason of the recall is ‘presence of foreign substance: Product complaint was received of metal contaminant observed in one tablet’. The product was distributed to distributors, mail order pharmacy and supermarkets throughout the US.

Lupin is an innovation led transnational pharmaceutical company developing and delivering a wide range of branded & generic formulations, biotechnology products and APIs globally.

Lupin Share Price

2324.25 -2.25 (-0.10%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×